兢仁品牌怎么样 申请店铺

我要投票 兢仁在医疗保健行业中的票数:70 更新时间:2025-02-06
兢仁是哪个国家的品牌?「兢仁」是 河南兢仁医疗生物科技有限公司 旗下著名品牌。该品牌发源于河南郑州,由创始人王帅旗在2018-08-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
兢仁怎么样

河南兢仁医疗生物科技有限公司定位以前沿高新技术为核心,专业致力于医疗设备、中医药及云医疗的技术研发和解决方案服务商,总部位于郑州市。公司通过自主创新研发为各级医疗机构多科室提供精准康复医疗设备和创新治疗方案,涵盖消化内科、神经内科、烧伤科、心内科、骨科、眼科、康复科等多科室,普及高端精准康复医疗、掌握行业核心技术、提升服务品牌价值。

人才和创新是发展的源泉,应用和普惠是发展的目的。公司形成了“传承、创新、突破、引领”的发展理念和“以客户为中心、以市场为导向、以创新为标准”产品研发思路,与国内著名医学院校和科研机构开创性的建立战略性联创孵化平台、产学研开发机制,汇集了一批掌握国内外高新技术的医学、光学、机械、电子及计算机技术的高级人才,各类专业技术人员占公司总人数的85%以上。

以“为人类解决病痛传递健康而持续创新和探索”为使命,坚持“人无我有,人有我优、人优我先”的创新发展理念,积极于专业领域内“零到壹技术突破”的尝试和探索,掌握核心技术普惠大众。秉承“德仁治企”的核心价值观,志在树立行业新典范、定义行业新标准、引领行业新发展,塑造普惠众人的知名品牌,打造让业界和国人尊重的现代健康企业集团。

Henan Jingren Medical Biotechnology Co., Ltd. is a technology R & D and solution provider specializing in medical equipment, traditional Chinese medicine and cloud medical technology, with its headquarter in Zhengzhou. Through independent innovation and research and development, the company provides precision rehabilitation medical equipment and innovative treatment scheme for multiple departments of medical institutions at all levels, including digestive medicine, neurology, burn department, cardiology, orthopedics, ophthalmology, rehabilitation department and other departments, popularizes high-end precision rehabilitation medicine, grasps industry core technology, and improves service brand value. Talent and innovation are the source of development, and application and inclusion are the purpose of development. The company has formed the development concept of "inheritance, innovation, breakthrough and guidance" and the product R & D thought of "customer-oriented, market-oriented and innovation standard". It has established a strategic joint innovation incubation platform, production, research and development mechanism with famous medical colleges and scientific research institutions in China, and has gathered a group of medical, optical, mechanical and electrical technology master high and new technology at home and abroad All kinds of professional and technical personnel account for more than 85% of the total number of the company. With the mission of "continuous innovation and exploration to solve human disease and deliver health", the company adheres to the innovative development concept of "people without me, people with me, people with me first", actively tries and explores "zero to one technology breakthrough" in the professional field, and grasps the core technology to benefit the public. Adhering to the core values of "governing enterprises by virtue and benevolence", the company aims to establish a new model of the industry, define new standards of the industry, lead the new development of the industry, build a well-known brand of inclusive people, and build a modern healthy enterprise group that is respected by the industry and the Chinese people.

本文链接: https://brand.waitui.com/4a0e07250.html 联系电话:13939072306

千城特选小程序码

7×24h 快讯

美股大型科技股盘前多数下跌,谷歌跌超7%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,谷歌跌超7%,亚马逊、苹果跌超1%,特斯拉跌0.92%,微软跌0.36%,Meta跌0.35%,奈飞跌0.14%;英伟达涨近1%。

48分钟前

热门中概股美股盘前多数走弱,拼多多跌超7%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超7%,理想汽车、微博跌超3%,阿里巴巴、京东、百度、蔚来跌超2%,小鹏汽车、爱奇艺跌超1%;B站涨超1%。

48分钟前

君实生物:AWT020注射用无菌粉末临床试验申请获批

36氪获悉,君实生物公告,近日,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,AWT020注射用无菌粉末(项目代号“JS213”)的临床试验申请获得批准。JS213是PD-1和白细胞介素-2双功能性抗体融合蛋白,主要用于晚期恶性肿瘤的治疗。

48分钟前

渣打集团任命Maria Ramos接替韦浩思担任集团主席

2月4日,渣打集团董事会宣布,鉴于韦浩思(José Viñals)已接近他服务满9年的任期,已任命Maria Ramos(65岁)接替韦浩思担任集团主席。待取得监管批准后,Maria将于公司在2025年5月8日举行的2025年股东周年大会后履新,而韦浩思届时将自董事会退任。(界面)

48分钟前

三六零:公司暂未向DeepSeek提供任何服务

36氪获悉,三六零公告,公司股票于2025年1月24日、1月27日、2月5日连续三个交易日内收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。经自查,公司注意到相关平台将公司股票纳入DeepSeek概念股。公司就相关事项澄清说明如下:在DeepSeek基于MIT开源协议的生态环境下,公司旗下的部分产品进行了DeepSeek的接入与本地化部署;公司暂未向DeepSeek提供任何服务。除上述事项外,公司未发现其他可能对公司股票交易价格产生较大影响的、需要公司澄清或回应的媒体报道或市场传闻

48分钟前

本页详细列出关于神奇的品牌信息,含品牌所属公司介绍,神奇所处行业的品牌地位及优势。
咨询